<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS: To define whether 1,25-dihydroxy <z:chebi fb="0" ids="28940">vitamin D3</z:chebi> (1,25-<z:chebi fb="2" ids="29191">(OH)</z:chebi>(2) D(3)) can protect diabetic <z:hpo ids='HP_0000488'>retinopathy</z:hpo> and to investigate its impact on the expressions of vascular endothelial growth factor (VEGF) and transforming growth factor-β(1) (TGF-β(1)) in the retinas of rats with <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Male Sprague-Dawley (SD) rats were divided into <z:mpath ids='MPATH_458'>normal</z:mpath> control group, 1,25-<z:chebi fb="2" ids="29191">(OH)</z:chebi>(2) D(3) group and <z:mp ids='MP_0002055'>diabetes</z:mp> group </plain></SENT>
<SENT sid="2" pm="."><plain>The rats in 1,25-<z:chebi fb="2" ids="29191">(OH)</z:chebi>(2) D(3) group and <z:mp ids='MP_0002055'>diabetes</z:mp> group were established to type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> model with high-fat and high-sugar diet and <z:chebi fb="1" ids="9288">streptozotocin</z:chebi> (STZ) </plain></SENT>
<SENT sid="3" pm="."><plain>Meanwhile, the rats of 1,25-<z:chebi fb="2" ids="29191">(OH)</z:chebi>(2) D(3) group were treated with 1,25-<z:chebi fb="2" ids="29191">(OH)</z:chebi>(2) D(3) </plain></SENT>
<SENT sid="4" pm="."><plain>After 13 weeks, morphological changes of <z:chebi fb="46" ids="15035">retinal</z:chebi> tissues were observed under microscopes after <z:chebi fb="1" ids="51686">hematoxylin</z:chebi>-eosin staining </plain></SENT>
<SENT sid="5" pm="."><plain>VEGF and TGF-β(1) expressions in the <z:chebi fb="46" ids="15035">retinal</z:chebi> tissues were detected with immunohistochemistry staining </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: Pathological examination showed an appearance of <z:hpo ids='HP_0000969'>edema</z:hpo> and disordered arrangement of <z:chebi fb="46" ids="15035">retinal</z:chebi> tissues in <z:mp ids='MP_0002055'>diabetes</z:mp> group, but milder pathological changes in 1,25-<z:chebi fb="2" ids="29191">(OH)</z:chebi>(2) D(3) group </plain></SENT>
<SENT sid="7" pm="."><plain>VEGF and TGF-β(1) expressions of both <z:mp ids='MP_0002055'>diabetes</z:mp> group and 1,25-<z:chebi fb="2" ids="29191">(OH)</z:chebi>(2) D(3) group significantly increased (P&lt;0.05), but those of 1,25-<z:chebi fb="2" ids="29191">(OH)</z:chebi>(2) D(3) group were significantly lower than <z:mp ids='MP_0002055'>diabetes</z:mp> group (P&lt;0.05) </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSION: 1,25-<z:chebi fb="2" ids="29191">(OH)</z:chebi>(2) D(3) had partially protective effect on diabetic <z:hpo ids='HP_0000488'>retinopathy</z:hpo> of diabetic rats, the mechanism of which might inhibit VEGF and TGF-β(1) expressions in the <z:chebi fb="46" ids="15035">retinal</z:chebi> tissues </plain></SENT>
</text></document>